Device Trial Radar · NCT02663739
Zenith® TXD Post-market Surveillance in Japan
Last checked: Nov 20, 2026Latest source record: Jun 7, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
57
Actual
Start
Mar 2015
Primary completion
Mar 28, 2023
Study completion Mar 28, 2023
Sponsor
- Lead sponsor
- Cook Group IncorporatedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 26, 2016
Design
- Study type
- Observational
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a post-market surveillance study required by Japanese Regulatory Authorities as a condition of approval
Conditions
- Aortic Dissection
Interventions
Zenith® TXDDevice
Zenith® TXD Dissection Stent Graft System for treatment of patients with aortic dissection of the descending thoracic aorta
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of major adverse eventsTime frame: 5 years
Locations
27 sites in 1 country. Site status is shown where the registry gives one.
Kokura Memorial Hospital
Fukuoka, Japan
Kyushu University Hospital
Fukuoka, Japan
Minami Tohoku Hospital
Fukushima, Japan
24 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.